Concordia’s Photodynamic Therapy Laser Receives Premarket Approval

Categories
About this Disease New Findings

Concordia International Corp. said that the U.S. Food and Drug Administration has approved the Company’s premarket approval application for its Photofrin 630 PDT (photodynamic therapy) Laser.
http://www.photonics.com/Article.aspx?AID=60901